GW Pharmaceuticals Plc. Soared 1,030%, with More Gains to Come

By:
GW Pharmaceuticals Plc. Soared 1,030%, with More Gains to Come

123rf.com / alphaspirit / Standard License.

GW Pharmaceuticals Plc. is a biopharmaceutical company that discovers, develops, and commercializes cannabinoid prescription medicines.

Since May 10, 2013, the stock price has climbed 1,033%.

And there are even more gains ahead in the next year as the company receives approval to launch cannabis-based medicine.

One of its products, Sativex, is an oromucosal spray that’s a formulated extract of the cannabis sativa plant.

According to GW’s website, the biopharmaceutical firm is commercializing Sativex for MS in 16 countries outside of the United States.

View Original Article Here

Repost is the designation for articles collected from the Internet whose content may interest our readers. These articles are not written by our staff and they do not necessarily reflect our views.

Related posts

Top